Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLASH: Finafloxacin Regimens for H. pylori Eradication
NCT00723502Phase 2Completed
- Sponsor
- MerLion Pharmaceuticals
- Start
- Sep 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finafloxacin in Helicobacter pylori infection, sponsored by MerLion Pharmaceuticals. Started Sep 2008; status: completed.
02
Drugs
finafloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00723502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723502.